Commentary Open Access
Volume 1 | Issue 3 | DOI: https://doi.org/10.46439/pediatrics.1.014
Hypothermic neuroprotection following neonatal hypoxic-ischemic encephalopathy: medico-legal implications
Steven M. Donn1,*, Jonathan M. Fanaroff2
- 1Department of Pediatrics, Division of Neonatal-Perinatal Medicine, C.S. Mott Children’s Hospital, Michigan Medicine, Ann Arbor, MI, United States
- 2Department of Pediatrics, Division of Neonatology, Rainbow Babies & Children’s Hospital, Case Western University, Cleveland, OH, , United States
Corresponding Author
Steven M. Donn, smdonnmd@med.umich.edu
Received Date: October 19, 2021
Accepted Date: December 16, 2021
Donn SM, Fanaroff JM. Hypothermic neuroprotection following neonatal hypoxic-ischemic encephalopathy: medico-legal implications. Clin Pediatr Neonatol. 2021; 1(3):53-54.
Copyright: © 2021 Donn SM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Commentary on “Calcitonin-gene related peptide and neurologic injury: An emerging target for headache management”
Mehkri et al. have presented a thorough review of calcitonin-gene related peptide (CGRP) and its relationship with headaches, both primary (e.g., migraine headaches) and secondary headaches (e.g., headaches secondary to subarachnoid hemorrhage (SAH) and traumatic brain injury (TBI)).
Inhibiting hypoxia-inducible factor in T cells strengthens effector-memory function in CD8+ T cells
In a recent attempt to elucidate the role of HIF1α in modulating the fate of T cells, we have demonstrated that the targeted deletion of HIF1α, specifically in T cells, enhances the inflammatory capabilities and memory phenotype of CD8+ T cells. These findings validate that the T cell-specific ablation of HIF1α or pharmacological inhibition of HIF1α reduces the development of B16F10 melanomas, suggesting an improved anti-tumor immune response characterized by improved secretion of effector molecules, such as IFN-γ, granzyme B, and TNFα, in the CD8+ T cells. Thus, it appears that HIF1α might negatively influence specific effector functions of CD8+ T cells, which are crucial for destroying and targeting tumor cells.
The extract of Nicotiana glauca induces apoptosis in rhabdomyosarcoma cells
Cancer is a leading cause of childhood mortality, with rhabdomyosarcoma (RMS) being the most prevalent type diagnosed in approximately two-thirds of pediatric cancer cases, particularly the embryonal subtype. RMS represents the most common soft tissue sarcoma in children and adolescents, accounting for around 2-3.5% of all pediatric malignancies [1].
Toward a new approach to treating tumors: Inducing apoptosis by combining chemotherapy and mild hyperthermia
Our studies on the effects of mild hyperthermia (≤ 42°C) on prometaphase-arrested and interphase HeLa cells are reviewed. Mild heat treatment rapidly induces apoptosis in H-HeLa cells that have been arrested in prometaphase with spindle poisons. This is shown by the appearance of morphological changes characteristic of apoptosis, the activation of Caspase 3, and the fact that the changes are blocked by caspase inhibitors such as zVAD-fmk. The same treatment does not cause apoptosis in interphase cells, or in prometaphase-arrested cells of other HeLa strains such as HeLa S3, MKF, and WML. However, prometaphase-arrested cultures of those other HeLa strains can be made sensitive to mild heat treatment by simultaneous exposure to compounds such as navitoclax (ABT-263) which inhibit Bcl-2 family anti-apoptotic proteins. Interphase cells can be made sensitive to 42°C treatment by combining ABT-263 or ABT-199 with S63845, a potent and selective inhibitor of MCL-1.